Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery

Cochrane Database of Systematic Reviews

Volumn 2019, Issue 3, 2019, Pages

  Felder, Seth ^a   Rasmussen, Morten Schnack ^b   King, Ray ^c   Sklow, Bradford ^c   Kwaan, Mary ^c   Madoff, Robert ^c   Jensen, Christine ^c  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b BISPEBJERG HOSPITAL   (Denmark)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; ANTICOAGULANT AGENT;

ABDOMINAL SURGERY; ARTICLE; AUTOPSY; BLEEDING; CLINICAL OUTCOME; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; ECHOGRAPHY; EVIDENCE BASED MEDICINE; HOSPITALIZATION; HUMAN; LUNG EMBOLISM; LUNG SCINTISCANNING; MORTALITY; PELVIS SURGERY; PHLEBOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SYSTEMATIC REVIEW; THROMBOSIS; THROMBOSIS PREVENTION; TREATMENT DURATION; X-RAY COMPUTED TOMOGRAPHY; ABDOMEN; DRUG ADMINISTRATION; PELVIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; SURGERY; VENOUS THROMBOEMBOLISM; META ANALYSIS; POSTOPERATIVE CARE;

ABDOMEN; ANTICOAGULANTS; DRUG ADMINISTRATION SCHEDULE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PELVIS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VENOUS THROMBOEMBOLISM; HOSPITALIZATION; POSTOPERATIVE CARE; PULMONARY EMBOLISM;

EID: 85063607536     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004318.pub4     Document Type: Article

References (65)

1. Bergqvist D, Agnelli G, Cohen AT, Eldor A, Nilsson PE, Moigne-Amrani AL, et al., Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. New England Journal of Medicine 2002; 346 (13): 975-90. 3351279
2. Jørgensen LN, Lausen I, Rasmussen MS, Wille-Jørgensen P, Bergqvist D,. Prolonged thromboprophylaxis with low-molecular weight heparin following major general surgery: an individual patient data meta-analysis. Blood. 2002; Vol. 100: abstract 1952 (poster). 3351281
3. Kakkar VV, Balibrea JL, Martinez-Gonzalez J, Prandoni P,. Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study. Journal of Thrombosis and Haemostasis 2010; 8 (6): 1223-39. 9495827
4. Lausen I, Jensen R, Jorgensen LN, Rasmussen MS, Lyng KM, Andersen M, et al., Incidence and prevention of deep venous thrombosis occurring late after general surgery: Randomised controlled study of prolonged thromboprophylaxis. European Journal of Surgery 1998; 164: 657-63. 3351283
5. Rasmussen MS, Jorgensen LN, Wille-Jørgensen P, Nielsen JD, Horn A, Mohn AC, et al., Prolonged prophylaxis with dalteparin to prevent late thromboeembolic complications in patients undergoing major abdominal surgery: a multicenter randomised open-label study. Thrombosis and Haemostasis 2006; 4: 2384-90. 3351285
6. Sakon M, Kobayashi T, Shimazui T,. Efficacy and safety of enoxaparin in Japanese patients undergoing curative abdominal or pelvic cancer surgery: Results from a multicenter, randomized, open-label study. Thrombosis Research 2010; 125: 65-70. 9495829
7. Vedovati MC, Becattini C, Rondelli F, Boncompagni M, Camporese G, Balzarotti R, et al., Randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. Annals of Surgery 2014; 259 (4): 665-9. 9495831
8. Corr BR, Winter AM, Sammel MD, Chu CS, Gage BF, Hagemann AR,. Effectiveness and safety of expanded perioperative thromboprophlaxis in complex gynecologic surgery. Gynecologic Oncology 2015; 138 (3): 501-6. 9495833
9. Downs LS,. Women's Cancer Center Protocol #45: Prolonged venous thromboembolism prophylaxis with fondaparinux in gynecologic oncology patients: an open label phase ii trial. Clinicaltrials.gov 2012. 9495835
10. GlaxoSmithKline,. Clinical evaluation of GSK576428 (fondaparinux sodium) in prevention of venous thromboembolism after abdominal surgery. Clinicaltrials.gov July 10, 2009. 9495837
11. Huh W,. Extended deep venous thrombosis prophylaxis in gynecologic oncology surgery with intermittent compression devices (ICD) with or without postoperative arixtra (fondaparinux sodium): a randomized controlled trial. Clinicaltrials.gov March 27, 2017. 9495839
12. Krasiński Z, Szpurek D, Staniszewski R, Dzieciuchowicz Ł, Pawlaczyk K, Krasińska B, et al., The value of extended preoperative thromboprophylaxis with dalteparin in patients with ovarian cancer qualified to surgical treatment. International Angiology 2014; 33 (4): 365-71. 9495841
13. Rasmussen MS, Wille-Jørgensen P, Jørgensen LN, et al., Prolonged thromboprophylaxis with low molecular weight heparin (dalteparin) following major abdominal surgery prevents late VTE: the FAME study. Pathophysiology of Haemostasis and Thrombosis 2003; 33 (1): 77-104. 3351287
14. Rasmussen MS,. Does prolonged thromboprophylaxis improve outcome in patients undergoing surgery?. Cancer Treatment Reviews 2003; Suppl 2: 15-7. 9495843
15. Sakon M, Nakamura, M,. Darexaban (YM150) prevents venous thromboembolism in Japanese patients undergoing major abdominal surgery: Phase III randomized, mechanical prophylaxis-controlled, open-label study. Thrombosis Research 2012; 130 (3): 52-9. 9495845
16. Schmeler KM, Langley G, Cain K, Munsell MF, Ramirez PT, Soliman PT, et al., Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies. Gynecologic Oncology 2013; 128 (2): 204-8. 9495847
17. Zhang, Z,. The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. ChiCTR-IPR-15007324 Recruiting. 9495849
18. Campanini M (FADOI Foundation, Italy),. Rivaroxaban or placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer: a randomized, double blind, placebo-controlled study. Clinicaltrials.gov 2017. 9495851
19. Agnelli G, Bolis G, Capussotti L, Scarpa RM, Tonelli F, Bonizzoni E, et al., A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Annals of Surgery 2006; 243 (1): 89-95
20. Akay OM, Ustuner Z, Canturk Z, Mutlu FS, Gulbas Z,. Laboratory investigation of hypercoagulability in cancer patients using rotation thrombelastography. Medical Oncology 2009; 26 (3): 358-64
21. Amin AN, Lin J, Ryan A,. Need to improve thromboprophylaxis across the continuum of care for surgical patients. Advances in Therapy 2010; 27 (2): 81-93
22. Arnesen H, Dahl OE, Aspelin T, Seljeflot I, Kierulf P, Lyberg T,. Sustained prothrombotic profile after hip replacement surgery: the influence of prolonged prophylaxis with dalteparin. Journal of Thrombosis and Haemostasis 2003; 1: 971-5
23. Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA Jr, Caprini JA,. A validation study of a retrospective venous thromboembolism risk scoring method. Annals of Surgery 2010; 251 (2): 344-50
24. Bergqvist D, Arcelus JI, Felicissimo P, ETHOS investigators. Post-discharge compliance to venous thromboembolism prophylaxis in high-risk orthopaedic surgery:results from the ETHOS registry. Thrombosis and Haemostasis 2012; 107 (2): 280-7
25. Caprini JA, Arcelus JI, Reyna JJ,. Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Seminars in Hamatology 2001; 38 (2 Suppl 5): 12-9
26. Clarke-Pearson DL, Synan IS, Hinshaw WM, Coleman RE, Creasman WT,. Prevention of postoperative venous thromboembolism by external pneumatic calf compression in patients with gynecologic malignancy. Obstetrics and Gynecology 1984; 63: 92-8
27. Dahl OE, Aspelin T, Arnesen H, Sejlefjot I, Kierulf P, Ruyter R, et al., Increased activation of coagulation and formation of late deep venous thrombosis following discontinuation of thromboprophylaxis after hip replacement surgery. Thrombosis Research 1995; 80: 299-306
28. Diamantis T, Tsiminikakis N, Skordylaki A, Samiotaki F, Vernadakis S, Bongiorni C, et al., Alterations of hemostasis after laparoscopic and open surgery. Hematology 2007; 12 (6): 561-70
29. Eikelboom JW, Quinlan DJ, Douketis JD,. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 2001; 358: 9-15
30. Galster H, Kolb G, Kohsytorz A, Seidlmayer C, Paal V,. The pre-, peri-, and postsurgical activation of coagulation and the thromboembolic risk for different risk groups. Thrombosis Research 2000; 100 (5): 381-8
31. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, et al., Prevention of venous thromboembolism. Chest 2001; 119 (suppl 1): 132S-175S
32. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, et al., Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 338S-400S
33. Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, et al., Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (Suppl 2): e227S-77S
34. Gross ME, Vogler SA, Mone MC, Sheng X, Sklow B,. The importance of extended postoperative venous thromboembolism prophylaxis in IBD: a National Surgical Quality Improvement Program analysis. Diseases of the Colon and Rectum 2014; 57 (4): 482-9
35. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al., The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5298
36. Huber O, Bounameaux H, Borst F, Rohner A,. Postoperative pulmonary embolism after hospital discharge: an underestimated risk. Archives of Surgery 1992; 127: 310-3
37. Hull RD, Pineo GF, Stein PD, Mah AF, MacIsaac SM, Dahl OE, et al., Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Annals of Internal Medicine 2001; 135: 858-69
38. Iversen LH, Thorlasius-Ussing O,. Relations of coagulation test abnormalities to tumour burden and postoperative DVT in resected colorectal cancer. Thrombosis Haemostasis 2002; 87: 402-8
39. Jørgensen LN, Wille-Jørgensen P, Hauch O,. Prophylaxis of postoperative thromboembolism with low molecular weight heparins. British Journal of Surgery 1993; 80: 689-704
40. Kalka C, Spirk D, Siebenrock KA, Metzger U, Tuor P, Sterzing D, et al., Lack of extended venous thromboembolism prophylaxis in high-risk patients undergoing major orthopaedic or major cancer surgery. Electronic Assessment of VTE Prophylaxis in High-Risk Surgical Patients at Discharge from Swiss Hospitals (ESSENTIAL). Thrombosis and Haemostasis 2009; 102 (1): 56-61
41. Kehlet H,. Fast-track colonic surgery: status and perspectives. Recent Results Cancer Research 2005; 165: 8-13
42. Lindblad B, Sternby NH, Bergqvist D,. Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ 1991; 302: 709-11
43. Lyman GH, Bohlke K, Falanga A, American Society of Clinical Oncology. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. Journal of Oncology Practice 2015; 11 (3): e442-4
44. Mahla E, Lang T, Vicenzi MN, Werkgartner G, Maier R, Probst C, et al., Thromboelastography for monitoring prolonged hypercoagulability after major abdominalsurgery. Anesthesia and Analgesia 2001 March; 92 (3): 572-7
45. Merkow RP, Bilimoria KY, McCarter MD, Cohen ME, Barnett CC, Raval MV, et al., Post-discharge venous thromboembolism after cancer surgery: extending the case for extended prophylaxis. Annals of Surgery 2011 Jul; 254 (1): 131-7
46. Merkow RP,. Is there a role for extended venous thromboembolism chemoprophylaxis in IBD?. Diseases of the Colon and Rectum 2014; 57 (4): 413-4
47. Mismetti P, Laporte S, Darmon JY, Buchmüller A, Decousus H,. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 2001; 88(7): 913-30
48. Najjar PA, Madenci AL, Zogg CK, Schneider EB, Dankers CA, Pimentel MT, et al., Implementation of a comprehensive post-discharge venous thromboembolism prophylaxis program for abdominal and pelvic surgery patients. Joural of the American College of Surgeons 2016; 223 (16): 804-13
49. National Comprehensive Cancer Network. Cancer-Associated Venous Thromboembolic Disease. Https://www.nccn.org/professionals/physician-gls/pdf/vte.pdf (Version 1.2016); Vol. Accessed August 1, 2016
50. Nguyen NT, Owings JT, Gosselin R, Pevec WC, Lee SJ, Goldman C, et al., Systemic coagulation and fibrinolysis after laparoscopic and open gastric bypass. Archives of Surgery 2001; 136 (8): 909-16
51. Rahr HB, Sorensen JV, Larsen JF, Jensen FS, Bredahl C, Nieuwenhuizen W,. Haemostatic activation before and after surgery in patients with and without gastric malignancy. Thrombosis and Haemostasis 1994; 71: 713-8
52. Rahr HB, Fabrin K, Larsen JF, Thorlacius-Ussing O,. Coagulation and fibrinolysis during laparoscopic Cholecystectomy. Thrombosis Research 1999; 93: 121-7
53. Copenhagen, The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen, The Nordic Cochrane Centre, The Cochrane Collaboration, 2014
54. Rogers SO Jr, Kilaru RK, Hosokawa P, Henderson WG, Zinner MJ, Khuri SF,. Multivariable predictors of postoperative venous thromboembolic events after general and vascularsurgery: results from the patient safety in surgery study. Journal of the American College of Surgeons 2007; 204 (6): 1211-21
55. Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Guidelines Committee. Guidelines for deep venous thrombosis prophylaxis during laparoscopic surgery. Surgical Endoscopy 2007; April 5: 1
56. Scurr JH, Colerigde-Smith PD, Hasty JH,. Deep Venous thrombosis: a continuing problem. British Medical Journal 1988; 297: 28
57. Sterne JA, Egger M, Moher D (editors),. Chapter 10: Addressing reporting biases. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration,. Available from www.cochrane-handbook.org
58. Sweetland S, Green J, Liu B, Berrington de Gonzalez A, Canonico M, Reeves G, et al., Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ 2009; 339: b4583
59. Sørensen C, Andersen M, Kristiansen VB, Jensen R, Wille-Jørgensen P,. The occurrence of late thromboembolic complications after elective abdominal surgery. Ugskrift for Laeger 1990; 152: 1586-7
60. Tsiminikakis N, Chouillard E, Tsigris C, Diamantis T, Bongiorni C, Ekonomou C, et al., Fibrinolytic and coagulation pathways after laparoscopic and open surgery: a prospective randomized trial. Surgical Endoscopy 2009; 23 (12): 2762-9
61. Vaitkus PT, Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ, PREVENT Medical Thromboprophylaxis Study Group. Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients. Thrombosis and Haemostasis 2005; 93: 76-9
62. Wille-Jørgensen P, Jørgensen LN, Hauch O, Borris LC, Lassen MR, Nehen AM, et al., Potential influence of observer variation on thromboprophylactic studies. Hæmostasis 1992; 22: 211-5
63. Wille-Jørgensen P, Jorgensen LN, Crawford M,. Asymptomatic postoperative deep vein thrombosis and the developement of postthrombotic syndrome. A systematic review and meta-analysis. Thrombosis and Haemostasis 2005; 93: 236-41
64. Rasmussen MS, Wille-Jørgensen P,. Prolonged thromboprophylaxis for abdominal surgery. Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: 10.1002/14651858.CD004318 ]
65. Rasmussen MS, Jørgensen LN, Wille-Jørgensen P,. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD004318.pub2 ]